Preliminary Announcement of Final Results for the year ended 30 September 2018
FINANCIAL HIGHLIGHTS
| Ordinary Shares (as at 30 September): |
2018 |
|
2017 |
|
| |
|
|
| Net asset value per share |
87.59p |
80.82p |
| Cumulative distributions paid per share since launch |
50.00p |
46.00p |
| Total return per share |
137.59p |
126.82p |
| |
|
|
| Annual Returns per share (basic and diluted): |
|
|
| Revenue return |
(0.19)p |
(0.13)p |
| Capital return |
11.81p |
8.99p |
| Combined return |
11.62p |
8.86p |
| |
|
|
| Dividends per share: |
|
|
| Interim paid |
1.75p |
1.75p |
| Special dividend |
1.00p |
- |
|
| Final proposed/paid |
2.65p |
2.25p |
| Total dividend for year |
5.40p |
4.00p |
| |
|
|
| Ongoing Expense Ratio* |
1.87% |
|
2.13% |
|
| |
|
|
* Calculated using the AIC’s “Ongoing Charges” methodology.
CHAIRMAN’S STATEMENT
INTRODUCTION
I should like to start by welcoming any new shareholders who have joined us through the acquisition of Hargreave Hale AIM VCT 2 plc which completed on 23 March 2018, or through this year’s fundraising activities.
PERFORMANCE
At 30 September 2018, the Net Asset Value (NAV) was 87.59 pence which after adjusting for the dividends paid gives a Total Return since inception of 137.59 pence. The earnings per share combined return for the year was 11.62 pence (comprising a revenue loss of 0.19 pence and capital gains of 11.81 pence). We are pleased to report that the NAV Total Return (NAV plus dividends paid) for the period was a gain of 13.3% compared to a gain of 10.8% in the FTSE AIM All-share Total Return Index in the year to 30 September 2018.
INVESTMENTS
The investment manager, Hargreave Hale Limited, invested £10.1 million in 18 Qualifying Companies during the year (a further £2.6 million was invested by Hargreave Hale AIM VCT 2 plc into Qualifying Companies between 1 October 2017 and the acquisition date). The fair value of Qualifying Investments at 30 September 2018 was £87.6 million invested in 75 AIM companies and 7 unquoted companies. £67.3 million was held in a mix of cash and non-qualifying equities; more detail can be found in the investment manager’s report.
DIVIDEND
An interim dividend of 1.75 pence was paid on 31 July 2018 (Interim 2017: 1.75 pence).
Following a period of strong NAV growth and, in particular, the realisation of gains through the partial disposal of our investment in Zoo Digital, the Board was pleased to announce a special dividend of 1 penny per ordinary share on 19 September 2018. The dividend payment was made on 24 October 2018 to shareholders on the register on 28 September 2018.
A final dividend of 2.65 pence is proposed (2017: 2.25 pence) which, subject to shareholder approval at the Annual General Meeting, will be paid on 8 February 2019 to ordinary shareholders on the register on 18 January 2019.
The Directors continue to maintain their policy of targeting a tax free dividend yield equivalent to 5% of the year end NAV. The ability to pay dividends is also dependent on the Company’s available reserves and cash resources, the Companies Act and the Listing Rules. The policy is non binding and at the discretion of the Board. Dividend payments may vary from year to year in both quantum and timing. Dividends will vary with investment performance; in good years, the Directors may consider a higher dividend payment; in poor years, the Directors may reduce or even pay no dividend.
BUYBACKS
In total, 2,959,394 shares were purchased during the year at an average price of 80.67 pence per share. A further 1,410,686 shares have been purchased since the year end at an average price of 75.90 pence per share.
The Board continues to target a share price discount of 5% to the NAV per share (as measured against the mid-price) for market purchases. It should be emphasised that this target is non-binding and depends upon a range of factors, including the Company’s liquidity, it’s shareholder permissions and market conditions.
The Company has a 5 year average share price discount on buybacks of 5.55%.
ACQUISITION OF HARGREAVE HALE AIM VCT 2 PLC AND OFFER FOR SUBSCRIPTION
The offer for subscription announced on 12 February 2018 was closed on 4 July 2018, £25 million was raised and 29.3 million new ordinary shares were issued.
On 23 March 2018, the Company announced the approval to acquire the above named company. The assets and liabilities of Hargreave Hale AIM VCT 2 were acquired by Hargreave Hale AIM VCT 1 in consideration for the issue of 68,680,227 ordinary shares of 1 pence each in the capital of the Company to Hargreave Hale AIM VCT 2 shareholders. The scheme shares were issued at a ratio of 1.458754 scheme shares for each Hargreave Hale AIM VCT 2 share held.
The acquisition was implemented on a relative unaudited NAV basis, adjusted for the anticipated costs of the scheme. The merger and roll-over values were based on the latest unaudited valuations of the companies’ investments. The effect of the scheme was that Hargreave Hale AIM VCT 2 shareholders received Hargreave Hale AIM VCT 1 shares with the same total market value as at the scheme calculation date as their Hargreave Hale AIM VCT 2 shares. The total cost of undertaking the acquisition was £0.40 million of which £0.16 million was met by Hargreave Hale Limited.
COMPANY NAME CHANGE
With the acquisition now complete, the Board felt it appropriate to revise the name of your company to Hargreave Hale AIM VCT plc. The new name came into effect on 6 September 2018. There is no change to the company EPIC (stock market code), nor is there any need to make any change to your share certificates.
CURRENT OFFER FOR SUBSCRIPTION
The Directors of the Company announced on 19 September 2018 the launch of a new offer for subscription for shares to raise up to £20 million, together with an over-allotment facility of up to a further £10 million. The offer was approved by shareholders of the Company at a general meeting on 19 October 2018 and is open to both new and existing shareholders. On 28 November 2018, the Company announced it had received valid applications in excess of £20 million and accordingly, the Directors confirmed they were releasing £5 million of the available £10 million over-allotment facility. Since its launch, the offer has resulted in gross funds being received of £22.0 million and the issue of 27.3 million new shares in the Company to the date of this report.
COST EFFICIENCY
Your Board reviews costs incurred by the Company on a regular basis and are focused on maintaining a competitively low ongoing expense ratio. I am pleased to report that the year end ongoing expense ratio was 1.87% when calculated in accordance with the AIC’s “Ongoing Charges” methodology. The methodology includes indirect costs including those incurred by underlying investment funds such as the Marlborough Special Situation Fund which we calculate to be equivalent to 0.09%. These fees are included to provide shareholders with a more accurate measure of the costs within the VCT. As the investment manager to the Company and the investment advisor to the Marlborough Special Situation Fund Hargreave Hale Limited makes a pro-rata adjustment to its investment management fee to ensure the VCT is not charged twice for their services. In the year to 30 September 2018 a reduction of £37,800 was made to the annual management fee with regards to this.
Total costs as measured under the EU rules and published in the Company’s Key Information Document are also monitored by the Board. This measure is calculated using a different methodology and includes transaction costs therefore showing a higher figure than the published ongoing charge ratio.
CANCELLATION OF SHARE PREMIUM AND CAPITAL REDEMPTION RESERVE
At the general meeting of the Company held on 16 March 2018, a special resolution was passed approving the cancellation of the Company's share premium account and capital redemption reserve in order to create a pool of distributable reserves.
I am pleased to inform you that the cancellation of the share premium account and capital redemption reserve of the Company was confirmed by the High Court of Justice in England and Wales and accordingly, the amounts standing to the credit of the share premium account (£117.6m) and capital redemption reserve (£0.1m) of the Company as at 25 September 2018 have been cancelled.
HARGREAVE HALE LIMITED TAKEOVER AND TRADING NAME
In July 2017, it was announced that Canaccord Genuity Group Inc. through its UK and Europe based wealth management business Canaccord Genuity Wealth Management agreed to acquire Hargreave Hale Limited. The transaction was completed in September 2017. The fund management division of Hargreave Hale Limited is now known as ‘Canaccord Genuity Fund Management’ which is a trading name of Hargreave Hale Limited.
INVESTMENT MANAGEMENT FEE
As previously announced the Company and Hargreave Hale Limited, have agreed to increase the investment management fee payable from an amount equal to 1.5% of the Company's net assets to an amount equal to 1.7% of the Company's net assets. This increase has been made to obtain additional resource for the dedicated fund management team to support the adopted strategy of increasing our exposure to unquoted companies and will take effect from 1 April 2019.
VCT REGULATORY UPDATE
Through the budget delivered on 22 November 2017, the government announced substantial changes to the legislation governing the management of Venture Capital Trusts. Broadly speaking, the proposed changes are designed to bring greater focus to the scheme and encourage more investment into small British companies. These changes will come into effect in stages and some of these changes have now started to apply to your Company.
Some of these changes will have little or no impact on the management of your Company. The most significant of the changes will be the increase in the investment test with the minimum percentage of the Company that must be invested into Qualifying Companies increasing from 70% to 80% for accounting periods beginning on or after 6 April 2019. This becomes applicable for Hargreave Hale AIM VCT plc from 1 October 2019. To assist with this change, the period of disregard for the disposal of Qualifying Investments will be increased from 6 months to 12 months.
As described above, Venture Capital Trusts have up to three years to invest new funds into Qualifying Companies before those new funds are included within the investment test. The legislation includes an additional condition to encourage early investment into Qualifying Companies. The new condition requires 30% of the new funds to be invested into Qualifying Companies within 12 months of the end of the accounting period in which the VCT issues the new shares. This applies to all new funds raised by the Company on or after 1 October 2018.
VCT STATUS
For now, to maintain its status as a Venture Capital Trust, the Company is required to invest at least 70% of the net funds raised in any one accounting period, into Qualifying Companies by the start of the accounting period containing the third anniversary of the date on which the funds were raised, often referred to as the ‘investment test’. I am pleased to report that we continue to perform well against this test and, at the period end, the investment test was 93.20% when measured using HMRC’s methodology. The Company satisfied all other tests relevant to its status as a Venture Capital Trust.
KEY INFORMATION DOCUMENT
The EU’s PRIIPs regulation came into effect in January of last year, the purpose of which is to increase customer protection by improving the functioning of financial markets. The regulation requires the Company to publish a Key Information Document (KID). Retail investors must now be directed to this before buying shares in the Company. The KID is published on the Company website at www.hargreaveaimvcts.co.uk/document-library.
The document has been prepared using the methodology prescribed in the PRIIPS regulation. Concerns have been expressed within the industry that;
- the risk score may be understating the level of risk; and
- investment performance scenarios may indicate future returns for shareholders that are too optimistic.
It is hoped that these issues will be resolved in the future.
GENERAL DATA PROTECTION REGULATION
I am sure most of you are all too familiar with the new legislation concerning the protection of personal data that came into effect on 25 May 2018. We wrote to shareholders at the time and included copies of our privacy policy. A copy can be found on the Company website at www.hargreaveaimvcts.co.uk/document-library.
Through an enclosed form, we asked you to notify us of the details of any third parties such as your financial adviser that you would like us to share your data with. Thank you to those shareholders who have responded.
If you have not yet responded but would like your financial adviser to have access to information relating to your investment in the Company (number of shares held, value, dividend history, date of allotment etc), then please get in contact with us via email at aimvct@canaccord.com or by phone on 01253 754755 and request another form. We cannot share your shareholder information with your adviser without your active consent.
BOARD COMPOSITION
Your Directors review the composition and effectiveness of the Board at regular intervals to ensure that it continues to comply with the applicable regulations, is consistent with best practice and remains effective.
The new Corporate Governance Code came into effective on 1 January 2019 and for your Company will become effective on 1 October 2019. The AIC’s Code of Corporate Governance is currently being drafted. Your Board will review its composition again once the code has been finalised.
As previously announced, I am delighted to welcome Ashton Bradbury to the board as a non-executive director appointed on 14 May 2018. Ashton was previously Head of Equities at Old Mutual Global Investors (now called Merian Global Investors) and is an experienced fund manager. His skills and experience are complementary to the existing non-executive team and I am grateful for his input which offers us a different perspective.
With the changing landscape of VCT regulations, your Board will continue to regularly review its structure and consider appropriate adjustments.
POST PERIOD END UPDATE
The well documented decline in global stock markets made for a difficult first quarter within the current financial year with the NAV declining from 87.59 pence to 73.05 pence in the 3 months to 31 December 2018, equivalent to a fall of 15.5% after adjusting for the 1 pence special dividend paid on 24 October 2018. A number of the Top 10 holdings have suffered steep falls in the share prices.
The investment manager has continued to deploy capital into qualifying companies in line with the budget, despite the challenges within the public markets. £2.9m has been invested into new qualifying investments. £0.4m was invested into a qualifying company held in the portfolio, with £2.5m invested into 3 new qualifying companies, including one IPO. All 4 investments were into public companies.
As of 4 January 2019, the share price of 69.50 pence represented a discount of 4.9% to the last published net asset value per share.
OUTLOOK
We certainly live in “interesting times”. It is difficult to get away from the “Brexit” subject. It is impossible to know what the outcome of the various negotiations will be, which will result in uncertainty. Alas this has and will unsettle the stock markets. We can expect a turbulent ride in terms of our NAV until some clarity becomes evident. That said the outlook for most of our investments remains positive as mostly they are good, well run companies which will adapt to any new regulations to which they are exposed.
We adopted a strategy of increasing our exposure to unquoted companies and to that end your board agreed a very small increase in the management fee provided that the number of staff was increased. I am pleased to report that this has happened and we are seeing some very exciting opportunities. We expect to see a number of new unlisted investments in the forthcoming months. Whilst the current uncertainty may reduce the number of AIM IPOs in the short term, we expect further opportunities to arise from our existing portfolio.
Looking at Brexit it is easy to be a prophet of doom and gloom. Personally, I think the economy has held up very well given general uncertainty with employment at record levels and company profits reaching all-time highs. This should mean that careful stock selection in the area of the market in which we operate will be well rewarded, although it may take a little time to see the benefits.
SIR AUBREY BROCKLEBANK
Chairman
Date: 8 January 2019
STRATEGIC REPORT
The purpose of the strategic report is to inform shareholders on key matters and help them to assess how the Directors have performed in their duty to promote the success of the Company. The report has been prepared by the Directors in accordance with the requirements of Section 414A of the Companies Act 2006. The Company’s independent auditor is required by law to report on whether the information given within the strategic report is consistent with the financial statements and has been prepared in accordance with applicable legal requirements.
THE COMPANY AND ITS BUSINESS MODEL
The Company was incorporated and registered in England and Wales on 16 August 2004 under the Companies Act 1985, registered number 05206425.
The Company has been approved as a Venture Capital Trust by HMRC under Section 259 of the Income Taxes Act 2007. The shares of the Company were first admitted to the Official List of the UK Listing Authority and trading on the London Stock Exchange on 29 October 2004 and can be found under the TIDM code “HHV”. The Company is premium listed.
In common with many other VCTs, the Company revoked its status as an investment company as defined in Section 266 of the Companies Act 1985 on 23 May 2006 to facilitate the payment of dividends out of capital profits.
The Company’s principal activity is to invest in a diversified portfolio of qualifying small UK based companies, primarily trading on AIM, with a view to maximising tax free dividend distributions to shareholders.
The Company is an externally managed fund with a Board comprising of four non-executive directors, three of whom are independent. Hargreave Hale Limited acts as investment manager, administrator and custodian and provides the company secretary.
The Board has overall responsibility for the Company’s affairs including the determination of its investment policy, however, the Board may exercise these responsibilities through delegation to Hargreave Hale as it considers appropriate.
The Directors have managed and continue to manage the Company’s affairs in such a manner as to comply with Section 259 of the Income Taxes Act 2007.
INVESTMENT OBJECTIVES
The Company's investment objectives are:
- to invest in a diversified portfolio of small UK based companies on a high risk, medium term capital growth basis, primarily being companies which are traded on AIM and which have the opportunity for significant value appreciation;
- to invest in smaller companies which may not be readily accessible to private individuals and which also tend to be more risky;
- to maximise distributions to shareholders from capital gains and income generated from the Company's funds;
- targeted investment in equities which are non-qualifying investments on an opportunistic basis; and
- to maintain the Company’s exposure to small companies through an initial investment of new capital into the Marlborough Special Situations Fund pending investment into qualifying companies.
ASSET ALLOCATION
The Company will have a range of investments in four distinct asset classes:
- equity investments in qualifying companies, referred to as "Qualifying Investments". Qualifying Investments will:
- comprise qualifying holdings for a VCT as defined in Chapter 4 Part 6 of the Income Tax Act 2007;
- primarily be made in AIM companies, but the Company's investment manager will also consider NEX-quoted companies (formally ISDX) and private companies that meet the investment criteria summarised below; and
- vary in size typically from £250,000 to £3 million by cost;
- fixed income securities;
- bank deposits that are readily realisable; and
- non-qualifying equity exposure in the form of equity exposure to UK and international equities through targeted investments made on an opportunistic basis or through an investment into the Marlborough Special Situations Fund.
INVESTMENT MANAGER
The Company is managed by Hargreave Hale Limited which have been managing investments in UK Small and Micro Cap companies for 20 years and VCTs for 14 years. Hargreave Hale has a long-established reputation as a substantial investor in and a supporter of small British companies through the main market of the London Stock Exchange and AIM. As well as the Venture Capital Trust, the fund management team manages 6 unit trusts including the Marlborough Special Situations Fund, the Marlborough UK Micro-Cap Growth Fund and the Marlborough Multi-Cap Income Fund. The investments of the Company are co-managed by Giles Hargreave and Oliver Bedford with support from the rest of the Hargreave Hale fund management team. The breadth of the fund management team, the scale of investment into small companies and the investment manager’s track record help attract deal flow.
In accordance with the investment policy, the Company has made investments in the Marlborough Special Situations Fund, which has returned 3,205% (equivalent to an average 19.1% per annum to 30 September 2018) since Giles Hargreave took responsibility for it in July 1998.
INVESTMENT STRATEGY
QUALIFYING INVESTMENTS
The investment manager will maintain a diversified and fully invested portfolio of Qualifying Investments. The primary purpose of the investment strategy is to ensure the Company maintains its status as a VCT. To achieve this, the Company must have 70% (80% for accounting periods beginning on or after 6 April 2019) of all funds raised from the issue of shares invested in Qualifying Investments throughout accounting periods of the VCT beginning no later than three years after the date on which those shares are issued.
Although VCTs are required to invest and maintain a minimum of 70% (80% for accounting periods beginning on or after 6 April 2019) of their funds invested in Qualifying Investments as measured by the VCT rules, it is likely that the investment manager will target a higher threshold of approximately 80% (85% for accounting periods beginning on or after 6 April 2019) in order to provide some element of protection against an inadvertent breach of the VCT rules. The Company's maximum exposure to a single Qualifying Investment is limited to 15% of net assets at cost.
The key selection criteria used in deciding which Qualifying Investments to make include, inter alia:
- the strength and credibility of the management team;
- the business plan;
- the risk/reward profile of the investment opportunity;
- the quality of the finance function and budgetary process;
- the strength of the balance sheet relative to anticipated cash flow from operations; and
- the existing balance of investments within the portfolio of Qualifying Investments.
The investment manager follows a stock specific, rather than sector specific, investment approach and is more likely to provide growth and development capital than seed capital.
The investment manager will primarily focus on investments in companies with a quotation on AIM. The investment manager will also invest in private companies or those planning to trade on AIM. The investment manager prefers to participate in secondary issues of companies with an established track record that can be more readily assessed and greater disclosure of financial performance. Secondary issues are often priced at an attractive discount to the market price.
NON-QUALIFYING INVESTMENTS
The Company will have non-qualifying direct equity exposure to UK and international equities through targeted investments made on an opportunistic basis. This will vary in accordance with the investment manager's view of the equity markets and may fluctuate between nil and 30% (by market value) of the net assets of the Company. The investment manager will also invest in fixed income securities and cash.
The investment manager will invest up to 75% of the net proceeds of any issue of new shares into the Marlborough Special Situations Fund subject to a maximum of 20% (8.9% as at 30 September 2018) of the gross assets of the Company. This will enable the Company to maintain its exposure to small companies indirectly, whilst the investment manager identifies opportunities to invest directly into small UK companies through a suitable number of Qualifying Investments.
The allocation between asset classes in the non-qualifying portfolio will vary depending upon opportunities that arise with a maximum exposure of 100% of the non-qualifying portfolio to any individual asset class.
To the extent that any future changes to the Company’s investment policy are considered material, shareholder consent to such changes will be sought.
BUSINESS REVIEW
The chairman’s statement and investment manager’s report contain a balanced and comprehensive analysis of the business during the financial year and the position of the investments at the year end. The financial position of the Company at 30 September 2018 was strong with no debt or gearing.
KEY PERFORMANCE INDICATORS
At each board meeting, the Directors consider the following Key Performance Indicators (KPIs) to assess whether the Company is achieving its strategic objectives. The Directors believe these measures help shareholders assess how effectively the Company is applying its investment policy and are satisfied the results give a good indication the Company is achieving its investment objectives and policy. The KPIs are established industry measures.
Further commentary on the performance of these KPIs has been discussed in the chairman’s statement and investment manager’s report. In addition, the Board considers peer group comparative performance. Performance is also measured against the Company’s closest benchmark the FTSE Aim All-share Total Return. The Director’s consider this to be the most appropriate benchmark from a shareholder’s perspective, however, due to the investment restrictions placed on a VCT it is not wholly comparable.
- NET ASSET VALUE AND TOTAL RETURN
In the financial year under review, net assets increased from £66.0m to £154.8m. This increase was made up of £56.6m net assets acquired through the acquisition of Hargreave Hale AIM VCT 2 plc, £24.5m new shares issued through the offer for subscription, profit for the year of £15.0m, less buybacks of £2.4m and dividends paid of £4.9m. The net asset value per share increased from 80.82p to 87.59p resulting in a gain to ordinary shareholders of 10.77 pence per share (13.3%) after adjusting for dividends paid in the year. The total return increased by 8.5%. These results are in line with the Company’s long-term objective to achieve capital growth and the Board is pleased with this performance.
2. ONGOING CHARGES RATIO
The ongoing charges of the Company for the financial year under review represented 1.87% (2017: 2.13%) of average net assets, which remains competitive when compared with other VCTs. This ratio is calculated using the AIC’s “Ongoing Charges” methodology. Cost control and efficiency continues to be a key focus for your Board and they are satisfied with the result for the year.
- EARNINGS PER SHARE (BASIC AND DILUTED)
The Company’s earnings per share for the year ended 30 September 2018 was 11.62 pence per share (2017: 8.86 pence per share).
- DIVIDENDS PER SHARE
The Board’s policy is to target a tax free dividend yield equivalent to 5% of the year end NAV. The Board remains committed to maintaining a steady flow of dividend distributions to shareholders; however, dividends will vary with investment performance. The ability to pay dividends is dependent on the Company’s available reserves and cash resources, the Companies Act and the Listing Rules. The policy is non-binding and at the discretion of the Board. Dividend payments may vary from year to year in both quantum and timing.
Total dividends of 4.00 pence per share were paid during the year including an interim dividend of 1.75 pence which was paid on 31 July 2018. A special dividend of 1.00 pence per share was announced on 19 September 2018 and payment was made on 24 October 2018.
A final dividend of 2.65p will be proposed at the Annual General Meeting.
- PERCENTAGE INVESTED IN QUALIFYING COMPANIES
The investment test has increased from 88.59% to 93.20% in the year. The Company made 18 Qualifying Investments at a cost of £10.1m, 7 of which were investments into new Qualifying Companies. The fair value of the qualifying portfolio increased from £38.0m to £87.6m as a result of the above additions, the investments acquired through the acquisition of Hargreave Hale AIM VCT 2 and unrealised gains for the period. The Board is pleased with this result. The quantity and quality of qualifying investment dealflow can vary, however, the Board believes that the investment manager will invest a sufficient amount of capital into Qualifying Companies to meet the HMRC defined investment test on an ongoing basis.
For further details please refer to the investment managers report.
BORROWINGS
It is not the Company’s present intention to have any borrowings. The Company does, however, have the ability to borrow a maximum amount up to 15% of the "Adjusted Capital and Reserves" amount (as such term is defined in the Articles of Association of the Company), which is effectively the aggregate of the nominal capital of the Company issued and paid up and the amount standing to the credit of the consolidated reserves of the Company, less specified adjustments, exclusions and deductions.
BUYBACKS
Share buybacks remain an important practice to improve liquidity in the Company’s shares. In total, 2,959,394 shares were purchased during the year at an average price of 80.67 pence per share.
PRINCIPAL RISKS AND UNCERTAINTIES
The Directors acknowledge that they are responsible for the effectiveness of the Company’s risk management and internal controls and periodically review the principal risks faced by the Company at the quarterly board meetings. The Board may exercise these responsibilities through delegation to Hargreave Hale Limited as it considers appropriate. The principal risks facing the Company relate to the Company’s investment activities and include risks stated below:
| Risk |
Consequence |
How the Board mitigates risk |
| Venture Capital Trust approval risk – the Company operates in a complex regulatory environment and faces a number of related risks. A breach of Section 259 of the Income Taxes Act 2007 or the Finance Act could result in the disqualification of the Company as a VCT. |
Loss of VCT approval could lead to the Company losing its exemption from corporation tax on capital gains, shareholders losing their tax reliefs, and, in certain circumstances being required to repay the initial tax relief on their investment. |
To reduce this risk, the Board has appointed the investment manager, who has significant experience in venture capital trust management and reports to the Board regularly throughout the year. In addition, to provide further formal assurance, the Board has appointed Philip Hare & Associates LLP to monitor compliance with regulations and provide half yearly compliance reports to the Board. |
| Investment risk – Many of the Company’s investments are held in small, high risk companies which are either listed on AIM or privately held. |
Investment in poor quality companies could reduce the capital and income return to shareholders. Events such as economic recession and movements in interest rates could adversely impact smaller company valuations. Investments in small companies are often illiquid and may be difficult to realise. |
The investment manager maintains a broad portfolio of investments and holds regular company meetings to monitor investments and identify potential risk. Regular board meetings and dialogue with the Directors supports strong governance. Whilst tax legislation limits the Company’s maximum exposure to a single Qualifying Investment to 15% of net assets (at cost), the investment manager’s preference for portfolio diversification means that Qualifying Investments rarely exceed 5% of net assets. The funds liquidity is monitored on a monthly basis. |
| Compliance risk – The Company is required to comply with the rules of the UK Listing Authority, the Companies Act, Accounting Standards, the General Data Protection Regulation and other legislation. The Company is also a small registered Alternative Investment Fund Manager (“AIFM”) and has to comply with the requirements of the AIFM Directive. |
Failure to comply with these regulations could result in a delisting of the Company’s shares, financial penalties, a qualified audit report or loss of shareholder trust. |
Board members have considerable experience of operating at senior levels within quoted businesses. They receive regular updates on new regulation from their auditors, lawyers and other professional bodies. Requirements are continually reviewed, and the Board seeks legal advice when appropriate. |
| Operational risk and outsourcing – Failure in the investment manager/administrator or other appointed third party systems and controls or disruption to its business. |
Failures could put the assets of the Company at risk or result in reduced or inaccurate information being passed to the Board or shareholders.
Quality standards may be reduced through lack of understanding or loss of control.
|
The Board reviews the system of internal controls, both financial and non-financial, operated by the Company and Hargreave Hale Limited. Hargreave Hale Limited has controls in place to ensure that the Company’s assets are safeguarded. It also has in place its own risk management system which is reviewed regularly to ensure controls remain effective. Documented internal policies and procedures manuals are reviewed by senior management. A documented business continuity plan and a regularly tested disaster recovery plan are in place to mitigate risk. Where tasks are outsourced to other third parties, reputable firms are used and performance is reviewed periodically. |
| Reputational risk – Inadequate or failed controls. |
Realisation of this risk might result in breaches of regulations or loss of shareholder trust. |
The investment manager operates a robust risk management system which is reviewed regularly to ensure controls remain effective in mitigating risks to the Company. |
Additional risks and further details of the above risks and how they are managed are explained in the financial statements. Trends affecting future developments are discussed in the chairman’s statement and the investment manager’s report.
LONG TERM VIABILITY STATEMENT
In accordance with provision C.2.2 of the UK Corporate Governance Code, the Directors have carried out a robust assessment of the principal risks relating to the Company. This assessment has been carried out over a longer period than the 12 months required by the ‘Going Concern’ provision. The Board conducted this review for a period of five years, which was selected because it:
- falls in line with the Company continuation vote and investors minimum holding period to retain tax relief; and
- covers a sufficient period for all funds raised to comply with HMRC investment test rules.
The Board considers the viability of the Company as part of its continuing programme of monitoring risk. The Company has a detailed risk control framework, documented procedures and forecasting model in place to reduce the likelihood and impact of risk taking that exceeds the agreed levels by the Board. These controls are reviewed by the Board and Hargreave Hale on a quarterly basis.
The Board has considered severe but reasonable scenarios and the effect of any mitigating actions, the potential impact of these risks on the business model, future performance and liquidity of the Company.
The Directors consider the Company to be viable for a further five years for the following reasons:
- the Company maintains a broad portfolio of investments including approximately £42.5 million invested in non-qualifying investments and a further £24.9 million in cash at the year end. The Company therefore has sufficient liquidity which is monitored monthly;
- the Company is well invested against the HMRC investment test and ended the year at 93.20% invested in qualifying companies. The Board anticipate that there will continue to be suitable Qualifying Investments available over the next five years;
- the ongoing expense ratio of the Company for the year end was 1.87%, which is competitive for the VCT sector;
- the financial position of the Company at 30 September 2018 was strong with no debt or gearing; and
- the Company has sufficient procedures in place to identify, monitor and control risk.
Based on this assessment, the Directors have a reasonable expectation that the Company will be able to continue in operation and meet its liabilities as they fall due over the next five years.
GENDER AND DIVERSITY
The Board comprises four male non-executive Directors with a diverse range of experience, skills, length of service and backgrounds. The Board confirms it will consider gender diversity when making future appointments and will always appoint the best person for the job. It will not discriminate on the grounds of gender, race, ethnicity, religion, sexual orientation, age or physical ability.
ENVIRONMENTAL RESPONSIBILITY
The Board conducts the Company’s affairs responsibly and expects the investment manager to consider environmental matters when appropriate. The Company offers electronic communications where acceptable to reduce the volume of paper it uses.
EMPLOYEE, HUMAN RIGHTS, SOCIAL AND COMMUNITY ISSUES
The Board seeks to conduct the Company’s affairs responsibly and expects the investment manager to consider employee, human rights, social and community issues when fulfilling their role. As an externally managed investment company with no employees, the Company does not maintain any specific policies in relation to these matters.
PROSPECTS
The prospects and future development of the Company are discussed in detail in the outlook section of the chairman’s statement.
By order of the Board of Directors.
STUART BROOKES
Company Secretary
Date: 8 January 2019
INVESTMENT MANAGER
Established in 1897, Hargreave Hale has evolved into a leading UK small cap fund manager and provider of investment management and stockbroking services to individuals, families, corporate entities, charities, trusts, solicitors, accountants and intermediaries. Hargreave Hale has an award-winning fund management team of 16 people.
On 18 September 2017, Hargreave Hale was acquired by Canaccord Genuity Wealth Management, the UK & Europe based wealth management business of Canaccord Genuity Group Inc.
The investment portfolio is co-managed by Giles Hargreave and Oliver Bedford, with support from Hargreave Hale’s fund management team of 16. The fund management team manages approximately £6.0 billion, including more than £4.5 billion invested in small companies (as at 30 September 2018). Along with the scale of the investment in small companies and their track record, the breadth of the team and their reach into the market help attract Qualifying Investment deal flow.
INVESTMENT MANAGER’S REPORT
INTRODUCTION
This report covers the 2017/18 financial year, 1 October 2017 to 30 September 2018. The investment manager’s report contains references to movements in the Net Asset Value (NAV) per share and Total Return per share (NAV per share plus distributed earnings per share). Movements in the NAV per share do not necessarily mirror the earnings per share (EPS) reported in the accounts and elsewhere, which convey the profit after tax of the Company within the reported period as a function of the weighted average number of shares in issue for the period.
Investment performance measures contained in this report are calculated on a pence per share basis and include realised and unrealised gains and losses.
INVESTMENT REPORT
In contrast to the stability of last year, the year under review has included more uncertainty. Although the current market correction did not fully materialise until after the year end, elements of the UK market have been in a sustained downturn since the summer. The political landscape, at home and abroad, is contentious and increasingly confrontational. More recently, commentators have started to question the capacity for the US economy to continue to grow, with the US yield curve hinting at a possible recession in late 2019 or 2020. US equities, in particular the large US technology companies, have had a substantial pullback, further damaging sentiment. In the UK, the economy has continued along its path of sub-trend growth.
More than ever, we continue to grapple with the potential direction and impact of Brexit on our portfolio. By and large, most companies continue to trade perfectly well. However, the uncertainty is clearly beginning to weigh on a small number of companies. With risks mounting, it seems inevitable that over the coming months, we will hear of more companies choosing to defer investment decisions, or of consumers taking a more cautious approach to discretionary spending. We have not observed Brexit related uncertainty influencing dealflow, although public market volatility has led to some companies choosing to defer their plans to float. It helps that we can now offer to meet their funding needs through a private (off-market) funding round. It is difficult to position the portfolio to meet an outlook which contains such a range of wildly different scenarios, but broadly speaking we are sitting in a more defensive posture with elevated cash balances and a focus on qualifying companies with robust non-secular/structural growth opportunities or, in the case of non-qualifying equities, higher quality FTSE 350 companies with support from structural growth, income or overseas earnings.
PERFORMANCE
In the twelve months to 30 September 2018, the NAV increased from 80.82p to 87.59p. A total of 4 pence per share was paid in dividends, giving investors a combined return of 10.77 pence per share, which translates to a gain of 13.3%. During the same period, the FTSE AIM All-Share Total Return gained 10.8%, whilst the FTSE 100 Total Return gained 6.1%.
The Qualifying Investments made a net contribution of 8.43 pence per share. The adjusting balance was the net of non-qualifying portfolio gains, running costs and investment income.
Learning Technologies Group was the top performing qualifying investment (+210.8%, +3.81 pence per share) delivering strong interim results in September 2018 and upgraded guidance which included the accelerated release of PeopleFluent synergies and continued growth in recurring revenues. Zoo Digital was the second largest contributor to positive performance (+229.7%, +3.45 pence per share), with the market responding positively to evidence of further traction in their new dubbing service. Creo (+174.1%, +1.74 pence per share), Craneware (+153.8%, +1.5 pence per share) and Ideagen (+98.8%, +1.16 pence per share) were also significant contributors over the period.
The biggest loss within the period came from Faron Pharmaceuticals (-87.5%, -1.32 pence per share) following the failure of the Phase III Traumakine trial. The double blinded multi-centre study failed to mirror the successful Phase II study with both arms of the study showing a below average mortality rate, with no discernible clinical benefit for those dosed with the active ingredient. Subsequent analysis has surfaced a possible link to the widespread use of steroids as part of the treatment regime, along with evidence that a patient’s genetic profile may influence the efficacy of the drug. Further data from a second clinical trial is expected shortly. Other losses came from Laundrapp (-73.5%, -0.79 pence per share) which we wrote down to the price of its latest funding round, Animalcare (-48.0%, -0.69 pence per share), Portr (-59.5%, -0.69 pence per share) which is subject to continuing uncertainty and Eagle Eye (-45.5%, -0.63 pence per share).
We invested £10.1m into 18 Qualifying Companies over the period, including 11 further investments into existing Qualifying Companies (3 private), 5 IPOs and 2 secondary placings into listed companies
Within the qualifying portfolio we reduced our investments in Zoo Digital, Creo, Aquis and Learning Technologies. All 4 companies experienced strong runs in the market. We completely exited TP Group earlier in the year and have reduced our holdings in Genedrive and Imaginatik following prolonged periods of poor performance.
PORTFOLIO STRUCTURE
The VCT is comfortably through the HMRC defined investment test and ended the period at 93.2% invested as measured by the HMRC investment test. By market value, the VCT had a 56.6% weighting to Qualifying Investments.
The allocation to non-qualifying equity investments decreased from 19.6% to 18.5%. We continued to make use of the Marlborough Special Situations Fund as a temporary home for proceeds from fundraising; the allocation decreased from 10.9% to 9.0%. The non-qualifying investments contributed +3.13 pence per share to the overall gains. The period ended with no fixed income investments and an increase in the cash weighting from 12.1% to 16.1%.
The HMRC investment tests are set out in Chapter 3 of Part 6 Income Tax Act 2007, which should be read in conjunction with this section of the annual report. Funds raised by VCTs are first included in the investment tests from the start of the accounting period containing the third anniversary of the date on which the funds were raised. Therefore, the allocation of Qualifying Investments as defined by the legislation can be different to the portfolio weighting as measured by market value relative to the net assets of the VCT.
POST PERIOD END UPDATE
The well documented decline in global stock markets made for a difficult first quarter within the current financial year with the NAV declining from 87.59 pence to 73.05 pence in the 3 months to 31 December 2018, equivalent to a fall of 15.5% after adjusting for the 1 pence special dividend paid on 24 October 2018. A number of the Top 10 holdings have suffered steep falls in the share prices.
We have continued to deploy capital into qualifying companies in line with the budget, despite the challenges within the public markets. £2.9m has been invested into new qualifying investments. £0.4m was invested into a qualifying company held in the portfolio, with £2.5m invested into 3 new qualifying companies, including one IPO. All 4 investments were into public companies.
As of 4 January 2019, the share price of 69.50 pence represented a discount of 4.9% to the last published net asset value per share.
For further information please contact:
STUART BROOKES |
| Company Secretary |
Registered office:
Hargreave Hale AIM VCT plc,
41 Lothbury
London
EC2R 7AE
01253 754740 |
| |
Date: 8 January 2019
STATEMENT OF DIRECTORS’ RESPONSIBILITIES
In respect of the financial statements
The Directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations. They are also responsible for ensuring that the annual report includes information required by the Listing Rules of the Financial Conduct Authority.
Company law requires the Directors to prepare financial statements for each financial year. Under that law the Directors are required to prepare the financial statements and have elected to prepare the company financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (“UK GAAP”) (United Kingdom Accounting Standards and applicable law). Under company law the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss for the Company for that period.
In preparing these financial statements, the Directors are required to:
- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- state whether they have been prepared in accordance with UK GAAP; subject to any material departures disclosed and explained in the financial statements;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business; and
- prepare a directors’ report, a strategic report and directors’ remuneration report which comply with the requirements of the Companies Act 2006.
The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company’s transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The Directors are responsible for ensuring that the annual report and accounts, taken as a whole, are fair, balanced, and understandable and provide the information necessary for shareholders to assess the Company’s position and performance, business model and strategy.
WEBSITE PUBLICATION
The Directors are responsible for ensuring the annual report and the financial statements are made available on a website. Financial statements are published on the Company’s website in accordance with legislation in the United Kingdom governing the preparation and dissemination of financial statements, which may vary from legislation in other jurisdictions. The maintenance and integrity of the Company's website is the responsibility of the Directors. The Directors' responsibility also extends to the ongoing integrity of the financial statements contained therein.
DIRECTORS' RESPONSIBILITY STATEMENT PURSUANT TO DTR4
Sir Aubrey Brocklebank (Chairman), David Brock, Oliver Bedford and Ashton Bradbury, the Directors confirm to the best of their knowledge that:
- The financial statements have been prepared in accordance with UK GAAP and give a true and fair view of the assets, liabilities, financial position and profit and loss of the Company; and
- The annual report includes a fair review of the development and performance of the business and the financial position of the Company, together with a description of the principal risks and uncertainties that it faces.
For and on behalf of the Board
SIR AUBREY BROCKLEBANK BT
Chairman
Date: 8 January 2019
INCOME STATEMENT
| |
|
Year to 30 September 2018 |
Year to 30 September 2017 |
| |
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
| Note |
|
£000 |
|
|
£000 |
|
|
£000 |
|
|
£000 |
|
|
£000 |
|
|
£000 |
|
| Net gain on investments held at fair value through profit or loss |
|
|
- |
|
|
16,519 |
|
|
16,519 |
|
|
- |
|
|
7,349 |
|
|
7,349 |
|
| Income |
|
|
806 |
|
|
78 |
|
|
884 |
|
|
446 |
|
|
15 |
|
|
461 |
|
| |
|
|
806 |
|
|
16,597 |
|
|
17,403 |
|
|
446 |
|
|
7,364 |
|
|
7,810 |
|
| Management fee |
|
|
(416 |
) |
|
(1,249 |
) |
|
(1,665 |
) |
|
(216 |
) |
|
(648 |
) |
|
(864 |
) |
| Other expenses |
|
|
(633 |
) |
|
(109 |
) |
|
(742 |
) |
|
(325 |
) |
|
(49 |
) |
|
(374 |
) |
| |
|
|
(1,049 |
) |
|
(1,358 |
) |
|
(2,407 |
) |
|
(541 |
) |
|
(697 |
) |
|
(1,238 |
) |
| (Loss)/gain on ordinary activities before taxation |
|
|
(243 |
) |
|
15,239 |
|
|
14,996 |
|
|
(95 |
) |
|
6,667 |
|
|
6,572 |
|
| Taxation |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
| (Loss)/gain after taxation |
|
|
(243 |
) |
|
15,239 |
|
|
14,996 |
|
|
(95 |
) |
|
6,667 |
|
|
6,572 |
|
| (Loss)/gain per share basic and diluted |
2 |
|
(0.19 |
)p |
|
11.81p |
|
|
11.62p |
|
(0.13)p |
8.99p |
8.86p |
The total column of these statements is the income statement of the Company. All revenue and capital items in the above statements derive from continuing operations. There was no other comprehensive income other than the gain/loss for the year.
The accompanying notes are an integral part of these financial statements.
BALANCE SHEET
Company Registration Number 5206425 (In England and Wales)
As at 30 September 2018
| |
|
|
2018 |
|
|
2017 |
|
| |
Note |
|
£000 |
|
|
£000 |
|
| |
|
|
|
| Fixed assets |
|
|
|
| Investments at fair value through profit or loss |
|
|
130,105 |
|
|
58,125 |
|
| |
|
|
|
| Current assets |
|
|
|
| Debtors |
|
|
167 |
|
|
63 |
|
| Cash at bank |
|
|
24,860 |
|
|
8,007 |
|
| |
|
|
25,027 |
|
|
8,070 |
|
| |
|
|
|
| Creditors: amounts falling due within one year |
|
|
(346 |
) |
|
(206 |
) |
| Net current assets |
|
|
24,681 |
|
|
7,864 |
|
| Total assets less current liabilities |
|
|
154,786 |
|
|
65,989 |
|
| |
|
|
|
| Capital and Reserves |
|
|
|
| Called up share capital |
|
|
1,767 |
|
|
816 |
|
| Share premium |
|
|
- |
|
|
37,515 |
|
| Capital redemption reserve |
|
|
5 |
|
|
37 |
|
| Special reserve |
|
|
125,919 |
|
|
15,522 |
|
| Capital reserve – realised |
|
|
(2,774 |
) |
|
(4,644 |
) |
| Capital reserve – unrealised |
|
|
30,606 |
|
|
17,237 |
|
| Revenue reserve |
|
|
(737 |
) |
|
(494 |
) |
| Total shareholders’ funds |
|
|
154,786 |
|
|
65,989 |
|
| |
|
|
|
| Net asset value per share (basic and diluted) |
3 |
87.59p |
80.82p |
These financial statements were approved and authorised for issue by the Board of Directors on 8 January 2019 and signed on its behalf by
SIR AUBREY BROCKLEBANK BT
Chairman
8 January 2019
The accompanying notes are an integral part of these financial statements.
STATEMENT OF CHANGES IN EQUITY
For the year ending 30 September 2018
|
|
Non-distributable reserves |
Distributable reserves (1) |
|
| |
Share Capital |
Share
Premium |
Capital Redemption Reserve |
Capital
Reserve Unrealised |
Special
Reserve |
Capital
Reserve
Realised |
Revenue
Reserve |
Total |
|
| |
|
£000 |
|
|
£000 |
|
|
£000 |
|
|
£000 |
|
£000 |
|
|
£000 |
|
|
£000 |
|
|
£000 |
|
|
| At 1 October 2017 |
|
816 |
|
|
37,515 |
|
|
37 |
|
|
17,237 |
|
15,522 |
|
|
(4,644 |
) |
|
(494 |
) |
|
65,989 |
|
|
| |
|
|
|
|
|
|
|
|
|
| Share buybacks |
|
(29 |
) |
|
- |
|
|
29 |
|
|
- |
|
(2,387 |
) |
|
- |
|
|
- |
|
|
(2,387 |
) |
|
| Share Issues |
|
293 |
|
|
24,707 |
|
|
- |
|
|
- |
|
- |
|
|
- |
|
|
- |
|
|
25,000 |
|
|
| Issue Costs |
|
|
(499 |
) |
|
|
|
|
|
|
(499 |
) |
|
| Acquisition of Hargreave Hale AIM VCT 2 plc |
|
687 |
|
|
55,919 |
|
|
- |
|
|
- |
|
- |
|
|
- |
|
|
- |
|
|
56,606 |
|
|
| Capital Reduction |
|
- |
|
|
(117,642 |
) |
|
(61 |
) |
|
- |
|
117,703 |
|
|
- |
|
|
- |
|
|
- |
|
|
| Equity dividends paid |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
(4,919 |
) |
|
- |
|
|
- |
|
|
(4,919 |
) |
|
| Realised gains on investments |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
- |
|
|
3,150 |
|
|
- |
|
|
3,150 |
|
|
| Unrealised gains on investments |
|
- |
|
|
- |
|
|
- |
|
|
13,369 |
|
- |
|
|
- |
|
|
- |
|
|
13,369 |
|
|
| Management fee charged to capital |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
- |
|
|
(1,249 |
) |
|
- |
|
|
(1,249 |
) |
|
| Income allocated to capital |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
- |
|
|
78 |
|
|
- |
|
|
78 |
|
|
| Due diligence investments costs |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
- |
|
|
(109 |
) |
|
- |
|
|
(109 |
) |
|
| Revenue loss after taxation for the year |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
- |
|
|
- |
|
|
(243 |
) |
|
(243 |
) |
|
| Total gain after taxation |
|
- |
|
|
- |
|
|
- |
|
|
13,369 |
|
- |
|
|
1,870 |
|
|
(243 |
) |
|
14,996 |
|
|
| At 30 September 2018 |
|
1,767 |
|
|
- |
|
|
5 |
|
|
30,606 |
|
125,919 |
|
|
(2,774 |
) |
|
(737 |
) |
|
154,786 |
|
|
Reserves available for distribution are capital reserve realised, special reserve and revenue reserve. Total distributable reserves at 30 September 2018 were £122.4 million. The accompanying notes are an integral part of these financial statements.
(1) The Income Taxes Act 2007 restricts distribution of capital from reserves created by the conversion of the share premium account into a special (distributable) reserve until the third anniversary of the share allotment that led to the creation of that part of the share premium account. As at 30 September 2018, £80.8 million of the special reserve is subject to this restriction.
For the year ending 30 September 2017
|
|
Non-distributable reserves |
Distributable reserves (1) |
|
| |
|
Share Capital |
Share
Premium |
Capital Redemption Reserve |
Capital
Reserve Unrealised |
Special
Reserve |
Capital
Reserve Realised |
Revenue
Reserve |
Total |
| |
|
|
£000 |
|
£000 |
|
£000 |
|
£000 |
|
£000 |
|
£000 |
|
|
£000 |
|
£000 |
|
| At 1 October 2016 |
|
|
|
620 |
|
21,845 |
28 |
9,651 |
|
19,052 |
|
(3,725) |
|
(399) |
|
47,072 |
|
| |
|
|
|
|
|
|
|
|
|
| Share buybacks |
|
|
|
(9) |
- |
9 |
- |
|
(668) |
- |
- |
|
(668 |
) |
| Share Issues |
|
|
|
205 |
|
16,013 |
- |
- |
- |
- |
- |
|
16,218 |
|
| Issue Costs |
|
- |
|
(343) |
- |
- |
- |
- |
- |
|
(343 |
) |
| Equity dividends paid |
|
- |
- |
- |
- |
|
(2,862) |
- |
- |
|
(2,862 |
) |
| Realised losses on investments |
|
- |
- |
- |
- |
- |
|
(237) |
- |
|
(237 |
) |
| Unrealised gains on investments |
|
- |
- |
- |
7,586 |
- |
- |
- |
|
7,586 |
|
| Management fee charged to capital |
|
- |
- |
- |
- |
- |
|
(648) |
- |
|
(648 |
) |
| Arrangement fee income |
|
- |
- |
- |
- |
- |
|
15 |
- |
|
15 |
|
| Due diligence investments costs |
|
- |
- |
- |
- |
- |
|
(49) |
- |
|
(49 |
) |
| Revenue loss after taxation for the year |
|
- |
- |
- |
|
- |
- |
|
(95) |
|
(95 |
) |
| Total gain after taxation |
|
- |
- |
- |
7,586 |
- |
|
(919) |
|
(95) |
|
6,572 |
|
| At 30 September 2017 |
|
|
|
816 |
|
37,515 |
37 |
17,237 |
|
15,522 |
|
(4,644) |
|
(494) |
|
65,989 |
|
Reserves available for distribution are capital reserve realised, special reserve and revenue reserve. Total distributable reserves at 30 September 2017 were £10.4 million. The accompanying notes are an integral part of these financial statements.
STATEMENT OF CASH FLOWS
|
|
|
|
2018 |
|
|
2017 |
| |
|
|
|
£000 |
|
|
£000 |
Total profit on ordinary activities before taxation
Realised (gain)/loss on investments
Unrealised (gain) on investments
(Increase) in debtors
Increase in creditors |
|
14,996
(3,150)
(13,369)
(104)
140 |
6,572
237
(7,586)
(19)
15 |
| Net cash (outflow) from operating activities |
|
|
|
(1,487) |
|
|
(781) |
Purchase of investments
Sale of investments |
|
(18,487)
13,016 |
(22,657)
10,453 |
| Net cash used in investment activities |
|
|
|
(5,471) |
|
|
(12,204) |
Share buybacks
Issue of share capital
Issue costs
Cash acquired on acquisition of Hargreave Hale AIM VCT 2 plc
Dividends paid |
|
(2,387)
25,000
(499)
6,616
(4,919) |
(668)
15,875
-
-
(2,862) |
| Net cash provided by financing activities |
|
|
|
23,811 |
|
|
12,345 |
| Net increase/(decreased) in cash |
|
|
|
16,853 |
|
|
(640) |
| Opening cash |
|
|
|
8,007 |
|
|
8,647 |
| Closing cash |
|
|
|
24,860 |
|
|
8,007 |
The accompanying notes are an integral part of these financial statements.
1. Basis of Preparation
The financial information set out in this preliminary announcement does not constitute the Company’s statutory accounts for the years ended 30 September 2018 or 30 September 2017. Statutory accounts for the year ended 30 September 2017 have been filed with the Registrar of Companies and those of the year ended 30 September 2018 will be delivered to the Registrar in due course; both have been reported on by the independent auditors. The independent auditor’s reports on the Statutory accounts for the years ended 30 September 2017 and 30 September 2018 were unqualified, did not draw attention to any matters by way of emphasis, and did not contain a statement under 498(2) or 498(3) of the Companies Act 2006.
The accounts of the Company are prepared in accordance with Accounting Standards applicable in the United Kingdom. UK Generally Accepted Accounting Practice (“GAAP”), including Financial Reporting Standard 102 (“FRS 102”) and with the Companies Act 2006 and the Statement of Recommended Practice for “Financial Statements of Investment Trust Companies and Venture Capital Trusts” (AIC SORP) (2014), updated January 2017. The accounting policies used in preparing this preliminary announcement are consistent with those used in the preparation of the financial statements.
All investments are classified as fair value through profit or loss. Investments are measured initially and subsequently at fair value which is deemed to be bid market prices for listed investments and investments traded on AIM. Unquoted investments are valued using the most appropriate methodology recommended by the International Private Equity Venture Capital (“IPEV”) guidelines published in December 2015. The Board will consider future updates in due course.
Where the classification of a financial instrument requires it to be stated at fair value, this is determined by reference to the quoted bid price in an active market wherever possible. Where no such active market exists for the particular asset or liability, the Company holds the investment at cost for a period or the price at the most recent funding round where there is considered to be no change in fair value.
Valuations of unquoted investments are reviewed on a quarterly basis and more frequently if events occur that could have a material impact on the investment. Where cost is no longer considered appropriate, the Company will use a value indicated by a material arms-length transaction by an independent third party in the shares of a company. Where no such transaction exists, the Company will use the most appropriate valuation technique including discounted cash flow analysis, earnings multiples, net assets and industry valuation benchmarks. All inputs are market observable with the exception of level 3 financial instruments.
Investments are recognised and derecognised at trade date where a purchase or sale is under a contract whose terms require delivery within the time frame established by the market concerned. Purchases and sales of unlisted investments are recognised when the contract for acquisition or sale becomes unconditional. Transaction costs are included in the initial cost or deducted from the disposal proceeds as appropriate.
These investments will be managed and their performance evaluated on a fair value basis in accordance with a documented investment strategy and information about them is provided internally on that basis to the Board.
Gains and losses arising from changes in fair value (realised and unrealised) are included in the net profit or loss for the period as a capital item in the income statement and are taken to the unrealised capital reserve or realised capital reserve as appropriate.
If an investment has been impaired such that there is no realistic expectation that there will be a full return from the investment, the loss is treated as a permanent impairment and transferred to the capital reserve realised.
Other financial assets and liabilities comprise receivables, payables and cash which are measured at amortised cost. There are no financial liabilities other than payables.
The accounting policies adopted in these preliminary results have been consistently applied to all the years presented and are consistent with the policies used in the preparation of the statutory accounts for the years ended 30 September 2018 and 30 September 2017. The full statutory annual accounts will be published in January 2019. Copies may in due course be obtained during normal business hours from Hargreave Hale Limited, Talisman House, Boardmans Way, Blackpool, FY4 5FY.
The Annual General Meeting of the Company will be held at the Company’s registered office on 5 February 2019 at 11.30am.
- Earnings per share (basic and diluted)
Revenue return per ordinary share is based on a net revenue loss on ordinary activities after taxation of £242,791 (2017 loss: £95,107) and on 129,091,888 (2017: 74,161,478) ordinary shares, being the weighted average number of ordinary shares in issue during the year.
Capital return per ordinary share is based on a net capital profit of £15,239,153 (2017 profit: £6,667,203) for the year and on 129,091,888 (2017: 74,161,478) ordinary shares, being the weighted average number of ordinary shares in issue during the year.
Total Return per ordinary share is based on a net profit of £14,996,362 (2017 profit: £6,572,097) for the year and on 129,091,888 (2017: 74,161,478) ordinary shares, being the weighted average number of ordinary shares in issue during the year.
- Net asset value per ordinary share
The net asset value per ordinary share at 30 September 2018 of 87.59 pence (2017: 80.82 pence) is based on net assets of £154,786,376 at the year end (2017: £65,988,872) and on 176,711,020 ordinary shares, being the number of shares in issue at year end (2017: 81,653,218).
- Principal Risks and Uncertainties
The principal risks facing the Company relate to the Company’s investment activities and include venture capital trust approval risk, investment risk, operational risk and outsourcing, compliance risk and reputational risk. Other risks faced by the Company include market risk, currency risk, interest rate risk and credit risk. These risks and the way in which they are managed are described in more detail in the Strategic Report.
- Related party transactions
Hargreave Hale Limited
Hargreave Hale Limited is considered to be a related party to the Company. Oliver Bedford, a non-executive director of the Company and a member of its key management personnel, is an employee of Hargreave Hale Limited. In addition, Hargreave Hale Limited acts as investment manager, administrator and custodian to the Company and it provides the company secretary. All of the support functions performed by Hargreave Hale Limited are segregated by department and location and are independent of each other.
Hargreave Hale Limited, in its capacity as investment manager of the fund, receives annual fees of 1.5% per annum of the net asset value of the Company, calculated and payable quarterly in arrears. Fees for the year are £1,665,754 (2017: £864,075). A further £494,733 was paid to Hargreave Hale Limited under the terms of the offer agreement. In relation to the other support functions described above, Hargreave Hale Limited received fees of £151,737 (2017: £100,000). Of those combined fees, £212,338 (2017: £99,095) was still owed at the year end.
Hargreave Hale Limited has agreed to indemnify the Company against annual running costs (such costs excluding VAT, any performance incentive fee and any trail commissions payable by the Company) exceeding 3.5% of its net assets. No fees were waived between 1 October 2017 and 30 September 2018 under the indemnity.
The Company and Hargreave Hale Limited, the Company's investment manager, have agreed to increase the investment management fee payable to Hargreave Hale from an amount equal to 1.5% of the Company's net assets to an amount equal to 1.7% of the Company's net assets, with effect from 1 April 2019.
.
6. Shares Issued
During the year, the Company issued 29,336,969 ordinary shares (nominal value £293,370) in an offer for subscription, representing 35.9% of the opening share capital at prices ranging from 84.45p to 89.38p per share. Gross funds of £25,000,000 were received of which £498,733 was paid to Hargreave Hale Limited to settle introductory commission due of £4,000 and to cover the costs of the offer.
The Company issued a further 68,680,227 ordinary shares (nominal value £686,802) in relation to the acquisition of Hargreave Hale AIM VCT 2 plc. The cash received from the acquisition was £6,615,786.
- Capital Structure
Share Capital
Ordinary shares are classed as equity. The ordinary shares in issue have a nominal value of one pence and carry one vote each. Substantial holdings in the Company are disclosed in the directors’ report.
Share Premium
This reserve represents the difference between the issue price of shares and the nominal value of shares at the date of issue, net of related issue costs.
Capital Redemption Reserve
This reserve is used for the cancellation of shares bought back under the buyback facility.
Special Reserve
Distributable reserve used to pay dividends and re-purchase shares under the buyback facility.
Capital Reserve Realised
Gains/losses on disposal of investments, due diligence costs and income from private company investments, permanent impairment of financial assets and 75% of the investment management fee are accounted for in the capital reserve realised.
Capital Reserve Unrealised
Unrealised gains and losses on investments held at the year end arising from movements in fair value are taken to the capital reserve unrealised.
Revenue Reserve
Net revenue profits and losses of the Company.
INVESTMENT PORTFOLIO SUMMARY
ORDINARY SHARE FUND
AS AT 30 SEPTEMBER 2018
| |
|
As at 30 September 2018 |
As at 30 September 2017 (3) |
|
|
|
| |
Net Assets % at 30/9/18 |
Book Cost £000 |
Cumulative Movement in value £000 |
Valuation £000 |
Book Cost £000 |
Cumulative Movement in value £000 |
Valuation £000 |
Change in Value for the year £000 (4) |
Market |
COI(1) |
|
| |
| Qualifying Investments |
|
| Learning Technologies Group plc |
5.56 |
|
2,586 |
6,020 |
|
8,606 |
|
663 |
1,018 |
|
1,681 |
5,002 |
|
AIM |
Y |
|
| Zoo Digital Group plc |
3.64 |
|
2,267 |
3,369 |
|
5,636 |
|
393 |
1,219 |
|
1,612 |
2,150 |
|
AIM |
Y |
|
| Creo Medical Group plc |
3.30 |
|
2,333 |
2,773 |
|
5,106 |
|
659 |
42 |
|
701 |
2,731 |
|
AIM |
Y |
|
| Ideagen plc |
2.65 |
|
1,992 |
2,113 |
|
4,105 |
|
410 |
555 |
|
965 |
1,558 |
|
AIM |
Y |
|
| SCA Investments Ltd (Gousto) |
2.29 |
|
2,486 |
1,061 |
|
3,547 |
|
1,002 |
(2 |
) |
1,000 |
1,063 |
|
Unlisted |
Y |
|
| Craneware plc |
2.09 |
|
125 |
3,109 |
|
3,234 |
|
125 |
1,149 |
|
1,274 |
1,960 |
|
AIM |
Y |
|
| Quixant plc |
1.67 |
|
1,209 |
1,378 |
|
2,587 |
|
160 |
1,370 |
|
1,530 |
8 |
|
AIM |
Y |
|
| Beeks Financial Cloud Group plc |
1.54 |
|
1,039 |
1,340 |
|
2,379 |
|
- |
- |
|
- |
1,340 |
|
AIM |
Y |
|
| Abcam plc |
1.53 |
|
55 |
2,308 |
|
2,363 |
|
55 |
1,625 |
|
1,680 |
683 |
|
AIM |
Y |
|
| Infinity Reliance Ltd (My 1st Years) |
1.45 |
|
2,504 |
(252 |
) |
2,252 |
|
501 |
(1 |
) |
500 |
(251 |
) |
Unlisted |
Y |
|
| Honest Brew Ltd |
1.42 |
|
2,203 |
(3 |
) |
2,200 |
|
501 |
(1 |
) |
500 |
(2 |
) |
Unlisted |
N |
|
| Aquis Exchange Ltd |
1.36 |
|
765 |
1,347 |
|
2,112 |
|
401 |
(1 |
) |
400 |
1,348 |
|
AIM |
Y |
|
| Cohort plc |
1.21 |
|
619 |
1,257 |
|
1,876 |
|
619 |
1,267 |
|
1,886 |
(10 |
) |
AIM |
Y |
|
| Loopup Group plc |
1.19 |
|
1,204 |
637 |
|
1,841 |
|
236 |
401 |
|
637 |
236 |
|
AIM |
Y |
|
| Hardide plc |
1.15 |
|
1,637 |
143 |
|
1,780 |
|
786 |
146 |
|
932 |
(3 |
) |
AIM |
Y |
|
| Science in Sport plc |
1.12 |
|
1,480 |
251 |
|
1,731 |
|
778 |
203 |
|
981 |
48 |
|
AIM |
Y |
|
| Zappar Ltd |
1.03 |
|
1,602 |
(2 |
) |
1,600 |
|
902 |
(2 |
) |
900 |
- |
|
Unlisted |
N |
|
| FairFX Group plc |
0.98 |
|
751 |
760 |
|
1,511 |
|
295 |
70 |
|
365 |
690 |
|
AIM |
N |
|
| DP Poland plc |
0.97 |
|
1,391 |
117 |
|
1,508 |
|
594 |
376 |
|
970 |
(259 |
) |
AIM |
Y |
|
| Mexican Grill Ltd (A Preference Shares) |
0.89 |
|
1,013 |
367 |
|
1,380 |
|
185 |
367 |
|
552 |
- |
|
Unlisted |
N |
|
| Portr Ltd |
0.80 |
|
1,790 |
(559 |
) |
1,231 |
|
873 |
125 |
|
998 |
(684 |
) |
Unlisted |
N |
|
| Eagle Eye Solutions Group plc |
0.77 |
|
1,643 |
(448 |
) |
1,195 |
|
967 |
234 |
|
1,201 |
(682 |
) |
AIM |
Y |
|
| Forbidden Technologies plc |
0.76 |
|
852 |
321 |
|
1,173 |
|
- |
- |
|
- |
321 |
|
AIM |
N |
|
| Clearstar Inc |
0.73 |
|
720 |
415 |
|
1,135 |
|
449 |
(134 |
) |
315 |
549 |
|
AIM |
Y |
|
| ULS Technology plc |
0.69 |
|
770 |
301 |
|
1,071 |
|
221 |
484 |
|
705 |
(183 |
) |
AIM |
Y |
|
| AnimalCare Group plc |
0.68 |
|
720 |
339 |
|
1,059 |
|
220 |
1,180 |
|
1,400 |
(841 |
) |
AIM |
Y |
|
| EKF Diagnostics Holdings plc |
0.68 |
|
565 |
488 |
|
1,053 |
|
300 |
160 |
|
460 |
328 |
|
AIM |
Y |
|
| Maxcyte Inc Com Stk USD 0.01 (DI) |
0.67 |
|
668 |
374 |
|
1,042 |
|
173 |
417 |
|
590 |
(43 |
) |
AIM |
Y |
|
| Angle plc |
0.64 |
|
1,159 |
(161 |
) |
998 |
|
348 |
(161 |
) |
187 |
- |
|
AIM |
N |
|
| Escape Hunt plc |
0.63 |
|
1,130 |
(152 |
) |
978 |
|
618 |
26 |
|
644 |
(178 |
) |
AIM |
Y |
|
| Everyman Media Group plc |
0.60 |
|
600 |
324 |
|
924 |
|
171 |
184 |
|
355 |
140 |
|
AIM |
Y |
|
| Osirium Technologies plc |
0.55 |
|
859 |
(7 |
) |
852 |
|
301 |
(38 |
) |
263 |
31 |
|
AIM |
Y |
|
| Cloudcall Group plc |
0.48 |
|
1,138 |
(389 |
) |
749 |
|
259 |
52 |
|
311 |
(441 |
) |
AIM |
Y |
|
| Surface Transforms plc |
0.47 |
|
639 |
83 |
|
722 |
|
373 |
(15 |
) |
358 |
98 |
|
AIM |
Y |
|
| K3 Business Technology Group plc |
0.47 |
|
270 |
450 |
|
720 |
|
270 |
198 |
|
468 |
252 |
|
AIM |
Y |
|
| KRM22 plc |
0.43 |
|
621 |
48 |
|
669 |
|
- |
- |
|
- |
48 |
|
AIM |
Y |
|
| CentralNic Group plc |
0.41 |
|
588 |
50 |
|
638 |
|
293 |
183 |
|
476 |
(133 |
) |
AIM |
Y |
|
| Idox plc |
0.41 |
|
135 |
497 |
|
632 |
|
135 |
1,027 |
|
1,162 |
(530 |
) |
AIM |
Y |
|
| Belvoir Lettings plc |
0.41 |
|
762 |
(133 |
) |
629 |
|
513 |
(127 |
) |
386 |
(6 |
) |
AIM |
Y |
|
| i-nexus Global plc |
0.41 |
|
701 |
(72 |
) |
629 |
|
- |
- |
|
- |
(72 |
) |
AIM |
Y |
|
| TrakM8 Holdings plc |
0.40 |
|
486 |
139 |
|
625 |
|
106 |
277 |
|
383 |
(138 |
) |
AIM |
N |
|
| Premaitha Health plc |
0.40 |
|
521 |
99 |
|
620 |
|
432 |
(179 |
) |
253 |
278 |
|
AIM |
N |
|
| Fulcrum Utility Services Ltd |
0.40 |
|
580 |
40 |
|
620 |
|
- |
- |
|
- |
40 |
|
AIM |
Y |
|
| Gfinity plc |
0.39 |
|
772 |
(172 |
) |
600 |
|
384 |
451 |
|
835 |
(623 |
) |
AIM |
Y |
|
| Tristel plc |
0.37 |
|
543 |
27 |
|
570 |
|
- |
- |
|
- |
27 |
|
AIM |
N |
|
| WANDisco plc |
0.33 |
|
347 |
165 |
|
512 |
|
89 |
311 |
|
400 |
(146 |
) |
AIM |
N |
|
| PCI-PAL plc |
0.32 |
|
811 |
(311 |
) |
500 |
|
- |
- |
|
- |
(311 |
) |
AIM |
Y |
|
| Plastics Capital plc |
0.32 |
|
478 |
19 |
|
497 |
|
250 |
45 |
|
295 |
(26 |
) |
AIM |
N |
|
| Instem plc |
0.32 |
|
297 |
196 |
|
493 |
|
297 |
(25 |
) |
272 |
221 |
|
AIM |
Y |
|
| The Property Franchise Group plc |
0.31 |
|
377 |
95 |
|
472 |
|
225 |
63 |
|
288 |
32 |
|
AIM |
Y |
|
| Laundrapp Ltd |
0.30 |
|
1,238 |
(770 |
) |
468 |
|
802 |
82 |
|
884 |
(852 |
) |
Unlisted |
N |
|
| Vertu Motors plc |
0.28 |
|
600 |
(170 |
) |
430 |
|
600 |
(127 |
) |
473 |
(43 |
) |
AIM |
N |
|
| bigblu Broadband plc |
0.27 |
|
347 |
73 |
|
420 |
|
154 |
104 |
|
258 |
(31 |
) |
AIM |
Y |
|
| MYCELX Technologies Corporation plc |
0.25 |
|
361 |
25 |
|
386 |
|
300 |
(171 |
) |
129 |
196 |
|
AIM |
Y |
|
| Globaldata plc |
0.22 |
|
173 |
167 |
|
340 |
|
173 |
136 |
|
309 |
31 |
|
AIM |
Y |
|
| Mirriad Advertising plc |
0.21 |
|
610 |
(283 |
) |
327 |
|
- |
- |
|
- |
(283 |
) |
AIM |
N |
|
| Faron Pharmaceuticals Oy |
0.21 |
|
2,220 |
(1,897 |
) |
323 |
|
201 |
399 |
|
600 |
(2,296 |
) |
AIM |
Y |
|
| Sanderson Group plc |
0.19 |
|
298 |
4 |
|
302 |
|
- |
- |
|
- |
4 |
|
AIM |
Y |
|
| Ilika plc |
0.19 |
|
507 |
(210 |
) |
297 |
|
218 |
(111 |
) |
107 |
(99 |
) |
AIM |
Y |
|
| APC Technology Group plc |
0.19 |
|
634 |
(338 |
) |
296 |
|
498 |
(343 |
) |
155 |
5 |
|
AIM |
Y |
|
| Intercede Group plc |
0.19 |
|
305 |
(18 |
) |
287 |
|
247 |
173 |
|
420 |
(191 |
) |
AIM |
N |
|
| Fusion Antibodies plc |
0.18 |
|
415 |
(129 |
) |
286 |
|
- |
- |
|
- |
(129 |
) |
AIM |
Y |
|
| Maxcyte Inc Com Stk USD0.01 (DI/REG S) |
0.16 |
|
264 |
(18 |
) |
246 |
|
141 |
(18 |
) |
123 |
- |
|
AIM |
Y |
|
| Velocity Composites plc |
0.14 |
|
624 |
(414 |
) |
210 |
|
332 |
(24 |
) |
308 |
(390 |
) |
AIM |
Y |
|
| Laundrapp Ltd (Loan Notes) |
0.13 |
|
200 |
- |
|
200 |
|
- |
- |
|
- |
- |
|
Unlisted |
N |
|
| Verona Pharma plc |
0.13 |
|
221 |
(23 |
) |
198 |
|
127 |
29 |
|
156 |
(52 |
) |
AIM |
Y |
|
| Lidco Group plc |
0.11 |
|
307 |
(137 |
) |
170 |
|
220 |
(69 |
) |
151 |
(68 |
) |
AIM |
N |
|
| Mexican Grill Ltd (Ordinary Shares) |
0.10 |
|
113 |
40 |
|
153 |
|
21 |
40 |
|
61 |
- |
|
Unlisted |
N |
|
| Universe Group plc |
0.09 |
|
210 |
(75 |
) |
135 |
|
210 |
30 |
|
240 |
(105 |
) |
AIM |
N |
|
| TLA Worldwide plc |
0.09 |
|
135 |
- |
|
135 |
|
300 |
(75 |
) |
225 |
75 |
|
AIM |
N |
|
| Pressure Technologies plc |
0.08 |
|
170 |
(40 |
) |
130 |
|
170 |
(40 |
) |
130 |
- |
|
AIM |
Y |
|
| Omega Diagnostics Group plc |
0.08 |
|
129 |
- |
|
129 |
|
- |
- |
|
- |
- |
|
AIM |
N |
|
| Reneuron Group plc |
0.08 |
|
606 |
(487 |
) |
119 |
|
534 |
(368 |
) |
166 |
(119 |
) |
AIM |
N |
|
| Medaphor Group plc |
0.07 |
|
300 |
(189 |
) |
111 |
|
250 |
(172 |
) |
78 |
(17 |
) |
AIM |
N |
|
| Porta Communications plc |
0.07 |
|
106 |
- |
|
106 |
|
505 |
(328 |
) |
177 |
328 |
|
AIM |
N |
|
| Egdon Resources plc |
0.06 |
|
158 |
(62 |
) |
96 |
|
158 |
(42 |
) |
116 |
(20 |
) |
AIM |
Y |
|
| Paragon Entertainment Ltd |
0.05 |
|
87 |
(9 |
) |
78 |
|
- |
- |
|
- |
(9 |
) |
AIM |
N |
|
| Mirada plc |
0.04 |
|
96 |
(27 |
) |
69 |
|
65 |
- |
|
65 |
(27 |
) |
AIM |
N |
|
| Genedrive plc |
0.04 |
|
68 |
- |
|
68 |
|
140 |
(80 |
) |
60 |
80 |
|
AIM |
N |
|
| Redcentric plc |
0.03 |
|
42 |
5 |
|
47 |
|
42 |
- |
|
42 |
5 |
|
AIM |
Y |
|
| Tasty plc |
0.03 |
|
40 |
- |
|
40 |
|
288 |
(188 |
) |
100 |
188 |
|
AIM |
N |
|
| Microsaic Systems plc |
0.02 |
|
26 |
4 |
|
30 |
|
10 |
- |
|
10 |
4 |
|
AIM |
N |
|
| Midatech Pharma plc |
0.02 |
|
53 |
(24 |
) |
29 |
|
37 |
- |
|
37 |
(24 |
) |
AIM |
Y |
|
| Mporium Group plc |
0.02 |
|
33 |
(8 |
) |
25 |
|
23 |
- |
|
23 |
(8 |
) |
AIM |
N |
|
| Flowgroup plc |
- |
|
26 |
(26 |
) |
- |
|
25 |
- |
|
25 |
(26 |
) |
AIM |
N |
|
| Imaginatik plc (2) |
- |
|
- |
- |
|
- |
|
323 |
(157 |
) |
166 |
157 |
|
AIM |
Y |
|
| Fusionex International plc (2) |
- |
|
- |
- |
|
- |
|
138 |
(80 |
) |
58 |
80 |
|
Unlisted |
N |
|
| Infoserve Group plc (2) |
- |
|
- |
- |
|
- |
|
- |
- |
|
- |
- |
|
Unlisted |
N |
|
| Total - Qualifying Investments |
56.61 |
|
62,525 |
25,123 |
|
87,648 |
|
24,784 |
13,139 |
|
37,923 |
11,984 |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| Non qualifying investments |
|
|
|
|
|
|
|
|
|
|
|
| Marlborough Special Situations Fund |
8.96 |
|
11,918 |
1,946 |
|
13,864 |
|
6,062 |
1,111 |
|
7,173 |
835 |
|
Unlisted |
Y |
|
| Total unit trusts |
8.96 |
|
11,918 |
1,946 |
|
13,864 |
|
6,062 |
1,111 |
|
7,173 |
835 |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| Royal Dutch Shell plc |
1.04 |
|
1,327 |
286 |
|
1,613 |
|
652 |
36 |
|
688 |
250 |
|
Main |
Y |
|
| BP plc |
0.99 |
|
1,203 |
329 |
|
1,532 |
|
600 |
21 |
|
621 |
308 |
|
Main |
N |
|
| NMC Health plc |
0.88 |
|
1,014 |
344 |
|
1,358 |
|
426 |
344 |
|
770 |
- |
|
Main |
Y |
|
| Melrose Industries plc |
0.84 |
|
1,455 |
(156 |
) |
1,299 |
|
926 |
(54 |
) |
872 |
(102 |
) |
Main |
Y |
|
| Hilton Food Group plc |
0.77 |
|
907 |
285 |
|
1,192 |
|
252 |
24 |
|
276 |
261 |
|
Main |
Y |
|
| Fulcrum Utility Services Ltd |
0.74 |
|
408 |
739 |
|
1,147 |
|
125 |
563 |
|
688 |
176 |
|
AIM |
Y |
|
| JD Sports Fashion plc |
0.72 |
|
855 |
265 |
|
1,120 |
|
463 |
31 |
|
494 |
234 |
|
Main |
Y |
|
| Anglo American plc |
0.71 |
|
931 |
172 |
|
1,103 |
|
422 |
33 |
|
455 |
139 |
|
Main |
Y |
|
| On the Beach Group plc |
0.64 |
|
846 |
144 |
|
990 |
|
391 |
140 |
|
531 |
4 |
|
Main |
Y |
|
| Dechra Pharmaceuticals plc |
0.63 |
|
951 |
28 |
|
979 |
|
461 |
191 |
|
652 |
(163 |
) |
Main |
Y |
|
| Vesuvius plc |
0.63 |
|
897 |
71 |
|
968 |
|
- |
- |
|
- |
71 |
|
Main |
Y |
|
| Sanne Group plc |
0.62 |
|
1,019 |
(61 |
) |
958 |
|
511 |
86 |
|
597 |
(147 |
) |
Main |
Y |
|
| Charter Court Financial Services Group plc |
0.58 |
|
732 |
171 |
|
903 |
|
- |
- |
|
- |
171 |
|
Main |
Y |
|
| Ascential plc |
0.58 |
|
768 |
133 |
|
901 |
|
326 |
43 |
|
369 |
90 |
|
Main |
N |
|
| XP Power Ltd |
0.42 |
|
660 |
(9 |
) |
651 |
|
292 |
13 |
|
305 |
(22 |
) |
Main |
Y |
|
| Future plc |
0.41 |
|
564 |
69 |
|
633 |
|
- |
- |
|
- |
69 |
|
Main |
Y |
|
| Oxford Biomedica plc |
0.41 |
|
612 |
17 |
|
629 |
|
- |
- |
|
- |
17 |
|
Main |
Y |
|
| Wizz Air Holdings plc |
0.38 |
|
622 |
(34 |
) |
588 |
|
220 |
123 |
|
343 |
(157 |
) |
Main |
N |
|
| Halma plc |
0.37 |
|
472 |
106 |
|
578 |
|
- |
- |
|
- |
106 |
|
Main |
Y |
|
| Micro Focus International plc |
0.37 |
|
509 |
63 |
|
572 |
|
141 |
80 |
|
221 |
(17 |
) |
Main |
N |
|
| Countryside Properties plc |
0.36 |
|
585 |
(31 |
) |
554 |
|
- |
- |
|
- |
(31 |
) |
Main |
Y |
|
| Prudential plc |
0.34 |
|
561 |
(33 |
) |
528 |
|
- |
- |
|
- |
(33 |
) |
Main |
N |
|
| FDM Group (Holdings) plc |
0.31 |
|
489 |
(4 |
) |
485 |
|
- |
- |
|
- |
(4 |
) |
Main |
Y |
|
| Bakkavor Group plc |
0.31 |
|
518 |
(35 |
) |
483 |
|
- |
- |
|
- |
(35 |
) |
Main |
Y |
|
| Quixant plc |
0.31 |
|
159 |
319 |
|
478 |
|
159 |
336 |
|
495 |
(17 |
) |
Main |
Y |
|
| Lloyds Banking Group plc |
0.31 |
|
549 |
(75 |
) |
474 |
|
285 |
(14 |
) |
271 |
(61 |
) |
Main |
Y |
|
| Horizon Discovery Group plc |
0.30 |
|
374 |
94 |
|
468 |
|
261 |
84 |
|
345 |
10 |
|
AIM |
Y |
|
| GVC Holdings plc |
0.30 |
|
459 |
- |
|
459 |
|
- |
- |
|
- |
- |
|
Main |
Y |
|
| IntegraFin Holdings plc |
0.29 |
|
279 |
173 |
|
452 |
|
- |
- |
|
- |
173 |
|
Main |
N |
|
| MYCELX Technologies Corporation plc |
0.29 |
|
298 |
150 |
|
448 |
|
200 |
(80 |
) |
120 |
230 |
|
AIM |
Y |
|
| Everyman Media Group plc |
0.29 |
|
293 |
155 |
|
448 |
|
85 |
87 |
|
172 |
68 |
|
AIM |
Y |
|
| Renishaw plc |
0.28 |
|
415 |
12 |
|
427 |
|
276 |
10 |
|
286 |
2 |
|
Main |
Y |
|
| Ricardo plc |
0.27 |
|
472 |
(51 |
) |
421 |
|
- |
- |
|
- |
(51 |
) |
Main |
Y |
|
| Cohort plc |
0.27 |
|
368 |
47 |
|
415 |
|
- |
- |
|
- |
47 |
|
AIM |
Y |
|
| Just Eat plc |
0.26 |
|
409 |
(7 |
) |
402 |
|
82 |
18 |
|
100 |
(25 |
) |
Main |
N |
|
| Clipper Logistics plc |
0.25 |
|
482 |
(96 |
) |
386 |
|
234 |
28 |
|
262 |
(124 |
) |
Main |
N |
|
| Fisher (James) & Sons plc |
0.25 |
|
355 |
25 |
|
380 |
|
- |
- |
|
- |
25 |
|
Main |
Y |
|
| Zotefoams plc |
0.21 |
|
323 |
(4 |
) |
319 |
|
- |
- |
|
- |
(4 |
) |
Main |
Y |
|
| GoCompare.com Group plc |
0.16 |
|
324 |
(81 |
) |
243 |
|
- |
- |
|
- |
(81 |
) |
Main |
Y |
|
| Mexican Grill Ltd (A Preference Shares) |
0.10 |
|
135 |
13 |
|
148 |
|
128 |
13 |
|
141 |
- |
|
Unlisted |
N |
|
| Regent Pacific Group Ltd |
0.08 |
|
201 |
(85 |
) |
116 |
|
150 |
(72 |
) |
78 |
(13 |
) |
Non UK Listed |
N |
|
| The Fulham Shore plc |
0.05 |
|
69 |
6 |
|
75 |
|
38 |
6 |
|
44 |
- |
|
AIM |
Y |
|
| Amerisur Resources plc |
0.05 |
|
212 |
(141 |
) |
71 |
|
167 |
(106 |
) |
61 |
(35 |
) |
AIM |
Y |
|
| Eagle Eye Solutions Group plc |
0.04 |
|
87 |
(18 |
) |
69 |
|
44 |
19 |
|
63 |
(37 |
) |
AIM |
Y |
|
| Egdon Resources plc |
0.03 |
|
47 |
6 |
|
53 |
|
- |
- |
|
- |
6 |
|
AIM |
Y |
|
| Reneuron Group plc |
0.02 |
|
119 |
(84 |
) |
35 |
|
104 |
(44 |
) |
60 |
(40 |
) |
AIM |
N |
|
| Midatech Pharma plc |
0.01 |
|
39 |
(17 |
) |
22 |
|
25 |
- |
|
25 |
(17 |
) |
AIM |
Y |
|
| Mexican Grill Ltd (Ordinary Shares) |
0.01 |
|
26 |
(7 |
) |
19 |
|
26 |
(7 |
) |
19 |
- |
|
Unlisted |
N |
|
| Hargreave Hale AIM VCT plc(2) |
- |
|
- |
1 |
|
1 |
|
- |
- |
|
- |
1 |
|
Main |
Y |
|
| Genagro Ltd (2) |
- |
|
- |
- |
|
- |
|
- |
- |
|
- |
- |
|
Unlisted |
Y |
|
| Total - Non-qualifying investments |
18.48 |
|
25,399 |
3,194 |
|
28,593 |
|
8,472 |
1,952 |
|
10,424 |
1,242 |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| Total - Non-qualifying investments |
27.44 |
|
37,317 |
5,140 |
|
42,457 |
|
14,534 |
3,063 |
|
17,597 |
2,077 |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| Total investments |
84.05 |
|
99,842 |
30,263 |
|
130,105 |
|
39,318 |
16,202 |
|
55,520 |
14,061 |
|
|
|
|
| Cash at bank |
16.06 |
|
|
|
24,860 |
|
|
|
|
|
|
|
|
| Prepayments & accruals |
(0.11 |
) |
|
|
(179 |
) |
|
|
|
|
|
|
|
| Net assets |
100.00 |
|
|
|
154,786 |
|
|
|
|
|
|
|
|
(1) COI – Co investments with other funds managed by Hargreave Hale at 30 September 2018.
(2) These are actual holdings of less than £500.
(3) Pre-acquisition of Hargreave Hale AIM VCT 2 plc.
(4) The change in fair value has been adjusted for additions and disposals in the year and as such does not reconcile to the unrealised total in Note 7 to the Annual Report and Financial Statements for the year ended 30 September 2018. The difference is £692k which is the total of ten full investment disposals in the year.
The comparative cost and valuations for 30 September 2017 do not agree to the Annual Report and Financial Statements for the year ended 30 September 2017 as the above list does not include brought forward investments that were fully disposed in the year.
TOP TEN INVESTMENTS
As at 30 September 2018 (by market value)
The top 10 equity investments are shown below; each is valued by reference to the bid price, or in the case of unquoted companies, values are either based on the last arm’s length transaction or valuation techniques, such as earnings multiples. Forecasts, where given, are drawn from a combination of broker research and/or Bloomberg consensus forecasts and exclude amortisation, share based payments and exceptional items. Forecasts are in relation to a period end for which the company results are yet to be released. Forecasts are not shown for private companies. The net asset figures are drawn from audited accounts and net cash values are from published accounts in most cases.
| Learning Technologies Group plc |
|
165.5p |
| Investment date |
November 2014 |
Forecasts for the year to |
December 2018 |
| Equity Held |
|
0.78% |
Turnover (£’000) |
97,800 |
| Av Purchase Price |
49.7p |
Profit/(loss) before tax (£’000) |
21,700 |
| Cost (£’000) |
|
2,586 |
Net Cash (£’000) |
1,048 |
| Valuation (£’000) |
|
8,606 |
Net Assets December 2017 (£’000) |
76,841 |
| |
| COMPANY DESCRIPTION |
| Learning Technologies Group provides a comprehensive and integrated range of e-learning services and technologies to corporate and government clients. The Group offers end-to-end learning and talent solutions ranging from strategic consultancy, through a range of content and platform solutions to analytical insights that enable corporate and government clients to meet their performance objectives. |
| Zoo Digital Group plc |
|
122.0p |
| Investment date |
April 2017 |
Forecasts for the year to |
March 2019 |
| Equity Held |
|
6.21% |
Turnover ($’000) |
|
33,700 |
| Av Purchase Price |
49.1p |
Profit/(loss) before tax ($’000) |
|
1,700 |
| Cost (£’000) |
|
2,267 |
Net Cash ($’000) |
|
(1,901) |
| Valuation (£’000) |
|
5,636 |
Net Assets March 2018 ($’000) |
|
2,655 |
| |
| COMPANY DESCRIPTION |
| Zoo Digital is a leading provider of cloud-based dubbing, subtitling, localisation and distribution services for the global entertainment industry. Zoo's clients are some of the best-known brands in the world including major Hollywood studios, global broadcasters and independent distributors. Zoo's point of difference in the marketplace is its development and use of innovative cloud technology that ensures that content is localised in any language and delivered to all the major online platforms such as Amazon, iTunes, Google and Hulu with reduced time to market, higher quality and lower costs. |
| Creo Medical Group plc |
|
222.0p |
| Investment date |
December 2016 |
Forecasts for the year to |
December 2018 |
| Equity Held |
|
1.92% |
Turnover (£’000) |
|
- |
| Av Purchase Price |
101.4p |
Profit/(loss) before tax (£’000) |
|
(11,042) |
| Cost (£’000) |
|
2,333 |
Net Cash (£’000) |
|
5,917 |
| Valuation (£’000) |
|
5,106 |
Net Assets June 2017 (£’000) |
|
14,653 |
| |
| COMPANY DESCRIPTION |
| Creo Medical is a medical device company focused on the emerging field of surgical endoscopy, a recent development in minimally invasive surgery. Creo Medical was founded in 2003, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques. |
| Ideagen plc |
|
159.0p |
| Investment date |
December 2014 |
Forecasts for the year to |
April 2019 |
| Equity Held |
|
1.18% |
Turnover (£’000) |
42,800 |
| Av Purchase Price |
77.2p |
Profit/(loss) before tax (£’000) |
11,400 |
| Cost (£’000) |
|
1,992 |
Net Cash (£’000) |
782 |
| Valuation (£’000) |
|
4,105 |
Net Assets April 2018 (£’000) |
50,484 |
| |
| COMPANY DESCRIPTION |
| Ideagen is a supplier of compliance-based information management software with operations in the UK and the United States. The company specialises in enterprise governance, risk and compliance and healthcare solutions for organisations operating within highly regulated industries. Ideagen provides complete content lifecycle solutions that enable organisations to meet their regulatory and quality compliance standards, helping them to reduce costs and improve efficiency. |
| SCA Investments Ltd (Gousto) (unquoted) |
|
5.299.0p |
| Investment date |
July 2017 |
Results for the year to |
December 2017 |
| Equity Held |
|
2.24% |
Turnover (£’000) |
|
23,204 |
| Av Purchase Price |
|
3,714.1 |
Profit/(loss) before tax (£’000) |
|
(13,426) |
| Cost (£’000) |
|
2,486 |
Net Cash (£’000) |
|
17,700 |
| Valuation (£’000) |
|
3,547 |
Net Assets December 2017 (£’000) |
|
18,781 |
| Income recognised in period (£) |
|
0 |
|
|
| |
| COMPANY DESCRIPTION |
| Founded in February 2012, Gousto is an e-commerce company offering recipe kit boxes which include fresh ingredients for step-by-step chef designed recipes to be made at home. Shoppers select meals from a variety of options on Gousto’s e-commerce platform. Gousto then delivers the pre-proportioned ingredients to the doorstep, along with instructions on how to prepare the meal. |
| Craneware plc |
|
3,300.0p |
| Investment date |
September 2007 |
Forecasts for the year to |
June 2019 |
| Equity Held |
|
0.37% |
Turnover ($’000) |
79,200 |
| Av Purchase Price |
127.6p |
Profit/(loss) before tax ($’000) |
23,900 |
| Cost (£’000) |
|
125 |
Net Cash ($’000) |
52,833 |
| Valuation (£’000) |
|
3,234 |
Net Assets June 2018 ($’000) |
51,646 |
| |
| COMPANY DESCRIPTION |
| Craneware develops and sells billing software analysis tools for the United States healthcare services sector. The company’s software automates the checking process, aids in cash flow and revenue generation, and ensures accurate submission of claims and management of compliance risks. |
| Quixant plc |
|
425.0p |
| Investment date |
May 2013 |
Forecasts for the year to |
December 2018 |
| Equity Held |
|
1.09% |
Turnover ($’000) |
123,000 |
| Av Purchase Price |
189.7p |
Profit/(loss) before tax ($’000) |
18,600 |
| Cost (£’000) |
|
1,368 |
Net Cash ($’000) |
2,544 |
| Valuation (£’000) |
|
3,065 |
Net Assets December 2017 ($’000) |
47,260 |
| |
| COMPANY DESCRIPTION |
| Quixant designs and manufactures complete advanced hardware and software solutions for the pay-to-play gaming industry. Quixant's specialised products provide an all-in-one solution, based on PC technology but with additional hardware features and operating software developed specifically to address the requirements of the gaming industry. |
| Beeks Financial Cloud Group plc |
|
126.0p |
| Investment date |
November 2017 |
Forecasts for the year to |
June 2019 |
| Equity Held |
|
3.72% |
Turnover (£’000) |
8,000 |
| Av Purchase Price |
55.0p |
Profit/(loss) before tax (£’000) |
2,100 |
| Cost (£’000) |
|
1,039 |
Net Cash (£’000) |
2,090 |
| Valuation (£’000) |
|
2,379 |
Net Assets June 2018 (£’000) |
4,844 |
| |
| COMPANY DESCRIPTION |
| Beeks Financial Cloud Group PLC operates as a cloud computing organisation. The Company focuses on providing a cloud platform for trading applications to connect to venues in financial cities and data centers. Beeks Financial Cloud Group serves financial market worldwide. |
| Abcam plc |
|
1,432.0p |
| Investment date |
October 2005 |
Forecasts for the year to |
June 2019 |
| Equity Held |
|
0.08% |
Turnover (£’000) |
265,000 |
| Av Purchase Price |
33.3p |
Profit/(loss) before tax (£’000) |
86,700 |
| Cost (£’000) |
|
55 |
Net Cash (£’000) |
90,200 |
| Valuation (£’000) |
|
2,363 |
Net Assets June 2018 (£’000) |
351,700 |
| |
| COMPANY DESCRIPTION |
| Abcam is a global life sciences company providing highly validated antibodies and other binders and assays to the research and clinical communities to help advance the understanding of biology and cause of disease. The company’s customers include universities, research institutes, and pharmaceutical and biotechnology companies in countries around the world. |
| |
| Cohort plc |
|
395.0p |
| Investment date |
February 2006 |
Results for the year to |
April 2019 |
| Equity Held |
|
1.42% |
Turnover (£’000) |
125,000 |
| Av Purchase Price |
170.2p |
Profit/(loss) before tax (£’000) |
16,100 |
| Cost (£’000) |
|
987 |
Net Cash (£’000) |
4,669 |
| Valuation (£’000) |
|
2,291 |
Net Assets April 2018 (£’000) |
74,930 |
| |
| COMPANY DESCRIPTION |
| Cohort plc provides electronic and surveillance technology solutions. The Company offers electronic warfare operational support, secure communication systems and networks, test systems, and data management. Cohort serves defense and security, transport, offshore energy, and other commercial markets. |
Investments held within the portfolio are listed and headquartered in the UK with the exception of the following:
| |
Listed |
Headquartered |
Registered |
| Listed investments: |
|
|
|
| Clearstar Inc |
UK |
Cayman Islands |
Cayman Islands |
| Faron Pharmaceuticals Oy |
UK |
Finland |
Finland |
| Fulcrum Utility Services Ltd |
UK |
UK |
Cayman Islands |
| GVC Holdings plc |
UK |
Isle of Man |
UK |
| Maxcyte Inc Com Stk USD 0.01 (DI) |
UK |
USA |
USA |
| Maxcyte Inc Com Stk USD 0.01 (DI/REG S) |
UK |
USA |
USA |
| MYCELX Technologies Corporation plc |
UK |
USA |
USA |
| Paragon Entertainment Ltd |
UK |
UK |
Cayman Islands |
| Regent Pacific Group Ltd |
Hong Kong |
Hong Kong |
Cayman Islands |
| Royal Dutch Shell plc |
UK |
Netherlands |
UK |
| Sanne Group plc |
UK |
Jersey |
Jersey |
| WANDisco plc |
UK |
UK and USA |
Jersey |
| Wizz Air Holdings plc |
UK |
Switzerland |
Jersey |
| XP Power Ltd |
UK |
Singapore |
Singapore |
| Unlisted private investments: |
|
|
|
| Fusionex International plc |
- |
UK |
Jersey |
| Genagro Ltd |
- |
Jersey |
Jersey |
STUART BROOKES
Company Secretary
Registered office:
Hargreave Hale AIM VCT plc,
41 Lothbury
London
EC2R 7AE
Date: 8 January 2019
